|
C2ORF60 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.855100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.446400E-02 |
| Normal-vs-Stage2 |
1.589580E-02 |
| Normal-vs-Stage3 |
3.536900E-03 |
| Normal-vs-Stage4 |
1.823840E-03 |
| Stage1-vs-Stage2 |
2.314200E-01 |
| Stage1-vs-Stage3 |
1.172570E-01 |
| Stage1-vs-Stage4 |
8.726500E-02 |
| Stage2-vs-Stage3 |
9.577200E-01 |
| Stage2-vs-Stage4 |
7.442800E-01 |
| Stage3-vs-Stage4 |
6.455800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.305970E-02 |
| Normal-vs-AfricanAmerican |
1.588040E-01 |
| Normal-vs-Asian |
1.886440E-01 |
| Caucasian-vs-AfricanAmerican |
8.206600E-01 |
| Caucasian-vs-Asian |
4.088400E-01 |
| AfricanAmerican-vs-Asian |
7.231600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.422400E-03 |
| Normal-vs-Female |
1.319650E-02 |
| Male-vs-Female |
7.790000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.221800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.431800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.360400E-03 |
| Normal-vs-Age(81-100Yrs) |
8.717300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.291000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.206200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.321800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.994800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.456600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.705600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.104200E-02 |
| Classical-VS-Follicular |
1.319960E-02 |
| Classical-VS-Other |
4.851200E-01 |
| Classical-VS-Normal |
8.963600E-02 |
| Tall-VS-Follicular |
9.328200E-01 |
| Tall-VS-Other |
8.128200E-01 |
| Tall-VS-Normal |
5.978800E-03 |
| Follicular-VS-Other |
8.226200E-01 |
| Follicular-VS-Normal |
2.478200E-03 |
| Other-VS-Normal |
1.725000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.264800E-03 |
| Normal-vs-N1 |
4.280100E-02 |
| N0-vs-N1 |
7.603800E-01 |
|
|
